Pharsight

Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

    Factors that can impact generic drug launch

    This page provides an overview of all the moving parts that affect generic drug approvals along with patent expirations. Stay up-to-date on major patent litigation cases, Para IV certification challenges, newly granted patents and exclusivities, and the many patent expirations coming up over the next decade.

    What happened recently?


    Recently expired drug patents
    Recently added drug patents
    Recently published drug patents
    Recent drug patent litigations

    Curated Collection ✨


    Drugs with Para IV expiring in 2023
    Drugs with expired main patents
    Drugs with SPC(s)
    List of Nephrology Drugs
    List of Diabetology Drugs

    Drug patents expiration in next 10 years


    Drug patents expiration in 2023
    Drug patents expiration in 2024
    Drug patents expiration in 2025
    Drug patents expiration in 2026
    Drug patents expiration in 2027
    Drug patents expiration in 2028
    Drug patents expiration in 2029
    Drug patents expiration in 2030
    Drug patents expiration in 2031

    Drugs facing NCE-1 Period


    Drugs facing NCE-1 Period in 2023
    Drugs facing NCE-1 Period in 2024
    Drugs facing NCE-1 Period in 2025
    Drugs facing NCE-1 Period in 2026
    Drugs facing NCE-1 Period in 2027
    Drugs facing NCE-1 Period in 2028
    Drugs facing NCE-1 Period in 2029
    Drugs facing NCE-1 Period in 2030
    Drugs facing NCE-1 Period in 2031